Thus, we speculated that circulating Alb/Fib ratio (AFR) and Fib/pAlb ratio (FPR), which reflected status of inflammation and nutrition, would be novel inflammatory biomarkers of prognostic prediction for postoperative stage II and III GC patients. The gene discussed is ALB; the disease is gastric cancer.